3Johnsson JR, Hickman IJ, Clouston AD, et al. Fibrosis in chronic hepatitis C correlates significantly with circulating C-peptide and insulin levels. Hepatology, 2002, 36: 272.
4Courouce AM, Le Marrec N, Bouchardeau F, et al. Efficacy of HCV core antigen detection during the preseroconversion period. Transfusion, 2000, 40: 1198-1202.
5Lee SR, Peterson J, Niven P, et al. Efficacy of a hepatitis C virus core antigen enzyme-linked immunosorbent assay for the identification of "window-phase" blood donations. Vox Sang , 2001, 80: 19-23.
6Bouvier-Alias M, Patel K, Dahari H, et al. Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication. Hepatology, 2002, 36: 211-218.
7Darius M, Takaji W, Katsutoshl T, et al. Characterization of three novel monoclonal antibodies against hepatitis C virus core protein. J Med Virol, 1996, 48: 234-241.
8Maillard P, Krawczynski K, Nitkiewicz J, et al. Nonenveloped nucleocapsids of hepatitis C virus in the serum of infected patients. J Virology, 2001, 75: 8240-8250.
9Aoyagi K,Ohue C,Iida K,et al. Development of a Simple and Highly sensitive enzyme immunoassay for hepatitis C virus core antigen. J Clin Microbiol, 1999, 37: 1802-1808.
